drugset / Trial / NCT00537472

Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time

NCT00537472 ↗

Completed 140 enrolled Queen's University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study plans to investigate whether a reduced dose of bupivacaine (a local anesthetic numbing drug) injected into the spinal space for a total knee replacement will result in a shorter time to discharge from the recovery room while maintaining adequate surgical anesthesia.

Timeline

Start
2007-10
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 9 mg Intrathecal
Subject Bupivacaine Other / unclassified 13 mg Intrathecal

Indications

No indication recorded.